Nagoya City Fire Bureau orders Airbus H160 helicopter

Bruno Even Chief Executive Officer Airbus Helicopters Airbus SE
Bruno Even Chief Executive Officer Airbus Helicopters - Airbus SE
0Comments

Japan’s Nagoya City Fire Bureau has placed an order for an Airbus H160 helicopter. The aircraft will be used for firefighting, search and rescue missions, and disaster response operations.

“We are honoured that our long-standing customer Nagoya City Fire Bureau has selected the H160 for their vital missions. This game-changing helicopter redefines safety, performance and design — ideally suited for demanding work of the Bureau,” said Jean-Luc Alfonsi, Managing Director of Airbus Helicopters in Japan. “We’re confident it will make a meaningful impact, and we remain fully committed to supporting their operations and deepening our partnership.”

The new H160 will be configured for search and rescue and aerial firefighting missions. It can be equipped with either a firefighting bucket or a belly-mounted water tank to assist ground crews in wildfire suppression.

The Nagoya City Fire Bureau began using helicopters in 1973 with its first aircraft, an Allouette III. Currently operating two AS365N3 helicopters, one will be retired with the introduction of the new H160.

The H160 is known for its advanced technology and operational safety while offering comfort. It can perform various missions including law enforcement, offshore transportation, private aviation, and emergency medical services. The model is already in service in several countries including Japan.

Airbus Helicopters has been active in Japan for 65 years with about 380 helicopters deployed across the country. The H160 is gaining popularity in Japan with three units currently flying — two for law enforcement and one for news gathering. This new order reflects growing confidence among Japanese operators in the helicopter’s capabilities.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.